Markel: The Berkshire Hathaway that nobody has on their radar
Scores at time of recommendation (April 6, 2026)
5-year stock timeline
Markel's arc from 2020 through 2026 traces a company learning to live with its own complexity. The pandemic hit underwriting hard in 2020, investment gains roared back in 2021, then 2022 delivered a sharp reset—substantial mark-to-market losses on equities and fixed income, a goodwill impairment at Nephila, and the CATCo buyout that fundamentally altered its insurance-linked securities exposure. By 2023, the narrative had steadied: meaningful investment gains returned (~$1.5 billion), Ventures delivered record revenues, buybacks accelerated to $445 million, and management tightened reserves on casualty lines that had drifted. The stock closed 2020 at $1,033.30 and 2023 at $1,419.90, with the latest price now at 1847.87.
What's worth holding: Markel's three-engine model—Insurance, Investments, Ventures—was always the thesis. In 2020 and 2021, that thesis looked like diversification. In 2022, when equity markets compressed and ILS positions bled, it looked like a liability. By 2023 onward, the company had proven it could absorb volatility without breaking stride, which is quieter but more durable than a simple story.
The technical progression matters. 2020–2021 was a recovery phase. 2021–2022 was a divergence phase—operating results holding up while mark-to-market losses created noise and doubt. 2023 consolidated that noise into clearer underwriting discipline and reserve actions. The larger buybacks and Ventures momentum that followed suggest management had conviction the worst of the reset was done.
What still moves the stock: realized investment gains (the company takes them when it wants), underwriting discipline on long-tail casualty lines (where adverse development appeared), and whether Ventures can sustain the revenue and EBITDA growth it showed in 2023. The three-engine framing only works if all three pull in the same direction. When they don't, volatility follows.
Key Points
- P/E ratio of 10.7x with earnings growth of 95% last year - that looks like a revaluation gap
- Price-to-book value of 1.2x: historically favorable for a company with an 11.8% return on equity
- Sales growth of almost 10% shows that the insurance business is picking up speed operationally
- Share buybacks underway - at below book value this would simply be capital allocation at Buffett level
- Expansion in US ocean freight business signals disciplined growth in niche markets
Investment Thesis
Markel is a specialty insurer that has been operating according to the same playbook for decades: disciplined underwriting in complex niche markets, combined with a long-term oriented investment portfolio. CEO Tom Gayner has managed the company since 1990 and has consistently increased the book value per share over this period. The model works because float from the insurance business serves as cheap capital for investments - a mechanism that has made Berkshire Hathaway great. The share is currently trading at a price-to-book ratio of 1.2x, which is unusually moderate for the quality of the company. Anyone with staying power and looking for quality at a reasonable price will find an easy-to-understand business model with a proven track record here.
Key risks and downside factors
Markel operates as a specialty property & casualty insurer with a dual mandate: underwriting combined with an investment and owner-operator approach. This structure exposes the business to both insurance-cycle fluctuations and market movements. The competitive landscape includes heavyweight diversified players like Berkshire Hathaway and Chubb alongside focused specialists such as W.R. Berkley, Arch Capital, Kinsale, and RLI. Distribution is fragmenting—MGAs and alternative capital sources are reshaping the market and compressing pricing power. The company's risk surface is multifaceted: underwriting volatility, catastrophe exposure, reserve adequacy, sensitivity across its investment portfolio, and the constraints imposed by capital and regulatory requirements all factor into returns and stability.
- Large competitors, MGAs, and alternative capital sources create underwriting-cycle pressures and pricing competition that can compress margins and erode underwriting discipline.
- Catastrophe and large-loss exposure can create reserve volatility and squeeze earnings when loss years turn adverse.
- Market volatility and extended periods of weak returns can eat into underwriting float benefits and slow surplus growth.
- Capital constraints, rising reinsurance costs, or shifts in the regulatory landscape could all work to constrain growth, push up the cost of capital, or force the company to reshape its product mix and risk appetite.
Competitive landscape
Markel Group (MKL) operates in specialty and commercial property-casualty insurance alongside competitors like Arch Capital, W. R. Berkley, Cincinnati Financial, and Berkshire Hathaway's insurance operations. The competitive landscape turns on underwriting discipline, access to specialty distribution channels, and investment performance—each of which creates real pressure on how Markel prices risk, reserves for losses, and deploys capital. The company faces meaningful headwinds: exposure to large catastrophic events, sensitivity to investment markets, ongoing pressure on both capital levels and credit ratings, and an increasingly crowded field of larger insurers and specialty MGAs pushing into its territory.
| Company | Ticker |
|---|---|
| Arch Capital Group Ltd | ACGL.NASDAQ |
| W. R. Berkley Corporation | WRB.NYSE |
Private competitors
- AmWINS Group
- RT Specialty
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialCatalysts
- Continuation of share buybacks at current valuation levels strengthens the book value per share
- Further premium growth in the specialty insurance segment, particularly in the newly expanded US freight business
- Positive development of the investment portfolio with stable or falling interest rates
- Increasing the operating margin in the insurance business through disciplined underwriting in market phases
- Possible revaluation by the market if there is a renewed focus on book value growth
Analysis
Performance Figures of Markel Corporation
Relative Performance vs Benchmarks
| Period | Markel Corporation | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | -3.20% | -7.91% | -8.65% |
| 3M | -10.84% | -10.30% | -20.54% |
| 6M | -11.18% | -16.68% | -21.62% |
| 1Y | -2.71% | -7.33% | -31.86% |
| 3Y | +39.08% | -18.56% | -46.59% |
| 5Y | +50.79% | -11.25% | -40.51% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 11.7 | 1.3 | 1.1 | 8.6 |
| 1Y ago | 13.3 | 1.6 | 1.4 | 10.5 |
| 3Y ago | 40.9 | 1.4 | 1.3 | 6.9 |
| 5Y ago | 6.1 | 1.4 | 1.3 | 8.6 |
Frequently Asked Questions
Is Markel Corporation a good investment?
What does Markel Corporation do?
What are the key metrics for MKL.NYSE?
How has Markel Corporation's stock price performed?
How is MKL.NYSE valued?
What are the growth catalysts for Markel Corporation?
- Continuation of share buybacks at current valuation levels strengthens the book value per share
- Further premium growth in the specialty insurance segment, particularly in the newly expanded US freight business
- Positive development of the investment portfolio with stable or falling interest rates
- Increasing the operating margin in the insurance business through disciplined underwriting in market phases
- Possible revaluation by the market if there is a renewed focus on book value growth
What are the key risks when investing in MKL.NYSE?
- Large competitors, MGAs, and alternative capital sources create underwriting-cycle pressures and pricing competition that can compress margins and erode underwriting discipline.
- Catastrophe and large-loss exposure can create reserve volatility and squeeze earnings when loss years turn adverse.
- Market volatility and extended periods of weak returns can eat into underwriting float benefits and slow surplus growth.
- Capital constraints, rising reinsurance costs, or shifts in the regulatory landscape could all work to constrain growth, push up the cost of capital, or force the company to reshape its product mix and risk appetite.
Who are the main competitors of Markel Corporation?
- Arch Capital Group Ltd (ACGL.NASDAQ)
- W. R. Berkley Corporation (WRB.NYSE)
When does Markel Corporation report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 16.59B | 16.75B | 15.71B | 11.81B | 12.92B |
| Operating income (EBIT) | 2.73B | 3.64B | 2.65B | -151.57M | 3.13B |
| Net income | 2.11B | 2.75B | 2.00B | -216.28M | 2.42B |
| Free cash flow | 2.55B | 2.34B | 2.53B | 2.45B | 2.13B |
| Total assets | 68.91B | 47.35B | 43.44B | 63.44B | 48.48B |
| Equity | 18.60B | 16.92B | 14.98B | 37.90B | 14.72B |
| Net debt | 339.11M | 1.45B | 636.35M | -33.80M | 844.15M |
PWP Leeway UG (haftungsbeschränkt)
